Your browser is no longer supported. Please, upgrade your browser.
Settings
AGN Allergan plc daily Stock Chart
AGN [NYSE]
Allergan plc
IndexS&P 500 P/E- EPS (ttm)-4.94 Insider Own0.10% Shs Outstand376.42M Perf Week0.63%
Market Cap71.96B Forward P/E11.89 EPS next Y16.07 Insider Trans1.80% Shs Float374.42M Perf Month1.25%
Income-1948.30M PEG- EPS next Q3.72 Inst Own88.50% Short Float7.27% Perf Quarter-20.05%
Sales14.90B P/S4.83 EPS this Y23.00% Inst Trans-4.29% Short Ratio5.81 Perf Half Y-23.38%
Book/sh215.93 P/B0.89 EPS next Y20.15% ROA10.30% Target Price265.11 Perf Year-39.60%
Cash/sh72.77 P/C2.63 EPS next 5Y12.50% ROE18.70% 52W Range184.50 - 317.48 Perf YTD-38.82%
Dividend2.80 P/FCF30.40 EPS past 5Y-50.40% ROI-1.30% 52W High-39.53% Beta1.02
Dividend %1.46% Quick Ratio3.90 Sales past 5Y33.40% Gross Margin83.30% 52W Low4.05% ATR6.76
Employees31200 Current Ratio4.00 Sales Q/Q4.40% Oper. Margin-9.80% RSI (14)40.23 Volatility1.99% 3.46%
OptionableYes Debt/Eq0.39 EPS Q/Q52.20% Profit Margin94.40% Rel Volume0.54 Prev Close191.18
ShortableYes LT Debt/Eq0.37 EarningsNov 10 BMO Payout0.00% Avg Volume4.69M Price191.97
Recom2.00 SMA20-2.34% SMA50-10.39% SMA200-19.34% Volume1,234,703 Change0.41%
Nov-17-16Reiterated Mizuho Buy $293 → $273
Nov-03-16Reiterated RBC Capital Mkts Outperform $300 → $279
Nov-01-16Reiterated Mizuho Buy $299 → $293
Oct-31-16Resumed Barclays Equal Weight $250
Oct-11-16Reiterated Mizuho Buy $305 → $299
Aug-19-16Upgrade Mizuho Neutral → Buy $248 → $318
Aug-09-16Reiterated RBC Capital Mkts Outperform $307 → $300
Aug-09-16Reiterated Deutsche Bank Buy $282 → $278
Aug-05-16Reiterated Mizuho Neutral $232 → $246
Jul-27-16Reiterated Leerink Partners Outperform $272 → $294
Jul-25-16Initiated Credit Suisse Outperform $327
May-13-16Reiterated Mizuho Neutral $250 → $232
Apr-18-16Resumed Goldman Buy $275
Apr-18-16Initiated Guggenheim Neutral
Apr-18-16Downgrade Piper Jaffray Overweight → Neutral $311 → $238
Apr-07-16Resumed Morgan Stanley Overweight $300
Apr-07-16Resumed JP Morgan Overweight
Apr-07-16Reiterated UBS Buy $366 → $300
Apr-07-16Downgrade Susquehanna Positive → Neutral
Apr-06-16Downgrade Mizuho Buy → Neutral $330 → $250
Dec-06-16 11:11AM  Teva shares plummet after key departure in generics business at CNBC
10:05AM  Questions Mount at Teva as Generics Head Quits Without Explanation
Dec-05-16 12:04PM  Allergan's Strength Lies In Its New Products And Robust Pipeline
10:10AM  SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Allergan PLC (AGN) and Lead Plaintiff Deadline: January 3, 2017 Accesswire
09:36AM  Amgen/Allergan File for EU Approval of Avastin Biosimilar
09:15AM  JP Morgan Positive on Allergan (AGN) at Investopedia
08:47AM  Amgen, Allergan File for Avastin Biosimilar in EU (AGN) at Investopedia
Dec-04-16 06:05PM  5 Healthcare Stocks Billionaires Love The Most at Insider Monkey
Dec-02-16 08:03PM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Allergan plc of Class Action Lawsuit and Upcoming Deadline - AGN Accesswire
04:32PM  Shire Loses Ground To Allergan In Thanksgiving Week Dry-Eye Scripts
03:49PM  Oaktree Reduces, Eliminates Multiple Positions in the 3rd Quarter
10:59AM  Billionaire Investors Are Bullish On These 5 Stocks at Insider Monkey
09:53AM  Allergan & Amgen Looking for Approvals (AGN, AMGN) at Investopedia
09:33AM  Amgen, Allergan apply for European nod for Avastin biosimilar Reuters
09:00AM  Amgen And Allergan Submit Biosimilar Marketing Authorization Application To European Medicines Agency For ABP 215, A Biosimilar Candidate To Bevacizumab PR Newswire
08:36AM  Stock Futures Hold Lower After U.S. Adds 178,000 Jobs
07:30AM  Allergan Provides Update on Accelerated Share Repurchase (ASR) Program PR Newswire
07:20AM  Allergan settles patent litigation with Zydus Pharma and Cadila regarding ulcerative colitis treatment at MarketWatch
07:00AM  Allergan Announces Settlement of a DELZICOL® (mesalamine) Patent Litigation PR Newswire
Dec-01-16 05:17PM  Allergan CEO: We're in era of populism & drug industry is...
03:56PM  Pharma execs weigh in on possible changes under Trump Reuters
02:22PM  Allergan CEO expects drug industry to face pricing heat from Trump Reuters
10:31AM  The Deal Economy Event Is Live
10:19AM  SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Allergan PLC (AGN) and Lead Plaintiff Deadline - January 3, 2017 Accesswire
09:18AM  Allergan CEO: 'I worry today that pharma has a false sense of relief or security' with Trump presidency
Nov-30-16 05:03PM  Valeant-Takeda Salix Negotiations Bust On $10 Billion Price: Report
12:06PM  Allergan's CEO Signals Confidence With $1 Million Purchase Of Stock at Forbes
11:24AM  Allergan Seeks to Reassure Antsy Investors but Will They Buy It?
08:05AM  Steady Rise: Allergans International Segment in 3Q16
Nov-29-16 05:04PM  Falling Revenue in Allergans US General Medicines Segment
03:45PM  Q3 Shows Hedge Funds Abandoning Healthcare Stocks (AGN, EBAY) at Investopedia
03:04PM  Allergans US Specialized Therapeutics Segment in 3Q16
02:18PM  Pfizer (PFE) Stock Rating Upgraded at Barclays
01:27PM  Understanding Allergans 3Q16 Revenue Stream
01:26PM  Analyzing Allergans Growth Pharma Plans
01:26PM  Allergans News: Recent Acquisitions and Divestments
01:26PM  Allergans Valuation Compared to Its Peers
10:55AM  Weekly CEO Buys Highlight
07:30AM  Allergan to Present at 2016 Citi Global Healthcare Conference PR Newswire
07:00AM  Carl Icahn Nearly Exits Allergan Position in Q3 (AGN, HLF) at Investopedia
Nov-28-16 03:06PM  Top Research Reports for Alphabet, Deere & Bristol-Myers
01:11PM  5 Healthcare Stocks Hedge Funds Are Dumping Like Crazy at Insider Monkey
12:01PM  3 Stocks That Had Billionaires Running for the Exit in Q3 at Motley Fool
10:10AM  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Allergan PLC (AGN) and Lead Plaintiff Deadline GlobeNewswire
08:49AM  Pharma Stock Roundup: Lilly Alzheimer's Drug Fails, J&J in Acquisition Talks with ALIOF
Nov-27-16 08:25PM  Is Nike Inc (NKE) Worthy of Your Portfolio? at Insider Monkey
06:00AM  SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In Allergan plc To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit AGN GlobeNewswire
Nov-25-16 08:00PM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Allergan plc of Class Action Lawsuit and Upcoming Deadline AGN GlobeNewswire
06:21PM  Ken Fisher Continues to Buy Allergan, HP, Lowe's
05:12PM  [$$] Clinical Development News, Nov. 21-25 at The Wall Street Journal
02:00PM  Allergan Could Pay $1 Billion for Chase Pharma
Nov-24-16 11:28AM  Hedge Funds Arent Crazy About Accenture Plc (ACN) Anymore at Insider Monkey
Nov-23-16 05:00PM  Allergan Makes Yet Another Acquisition at Investopedia
03:50PM  FDA Approves Allergan's Xen Glaucoma Stent (AGN) at Investopedia
02:13PM  Should You Avoid Allergan, Inc. (AGN)? at Insider Monkey
01:04PM  Targeted Acquisitions Have Strengthened Tevas Generic Business
12:58PM  Allergan Buys Alzheimer's Drug Maker for $125M (AGN) at Investopedia
12:10PM  [$$] Four traders exit Paulson & Co's London office at Financial Times
10:27AM  Allergan PLC Investors With Losses In Excess of $1,000,000 Are Reminded to Contact the Rosen Law Firm Regarding the Important Deadline in Class Action filed by Firm - AGN PR Newswire
10:03AM  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Allergan PLC (AGN) and Lead Plaintiff Deadline - January 3, 2017 Accesswire
07:59AM  Allergan Acquires Chase Pharma, Expands CNS Portfolio
06:00AM  Jim Cramer's Top Takeaways: Home Depot, Corbus Pharmaceuticals
Nov-22-16 04:15PM  Allergan Acquires Chase Pharmaceuticals to Expand CNS R&D Pipeline and Build on Commitment to Alzheimer's Disease PR Newswire
03:04PM  Understanding Eli Lillys Business Segments by 3Q16 Performance
02:12PM  CEO Saunders' Stake Fails to Bolster Allergan
12:27PM  Is Donald Trump a Blessing or a Curse for Big Pharma? at Motley Fool
09:41AM  The Chief Executive Officers of These Four Companies Buy Shares, Plus Insider Selling at Sanmina Corp (SANM) at Insider Monkey
08:16AM  Allergan's Fibristal Approved in Canada for Label Expansion
08:09AM  Teva's Leukemia Drug Gets EU Approval in First-Line Setting
07:35AM  Allergan Receives FDA Clearance for the XEN® Gel Stent, a New Surgical Treatment for Refractory Glaucoma PR Newswire
Nov-21-16 07:45PM  Should You Follow Ionic Capital Managements Lead And Cut Exposure To Allergan (AGN) & Three Other Stocks? at Insider Monkey
07:15PM  Allergan Plc (AGN) CEO and President Brent L Saunders Bought $992,932 of Shares
06:08PM  Jeff Auxier Expands Holdings in Chemical and Biotech Companies
04:19PM  Acorda Scrapping Stroke Drug Just 'Small Disappointment': RBC
01:35PM  Teva Pharmaceutical Expected to Report Robust Revenue in 2016
08:00AM  FIBRISTAL®, The First And Only Medication Indicated For Uterine Fibroids, Receives Approval From Health Canada For Long Term Intermittent Treatment PR Newswire
08:00AM  FIBRISTAL®, The First And Only Medication Indicated For Uterine Fibroids, Receives Approval From Health Canada For Long Term Intermittent Treatment CNW Group
Nov-20-16 09:00AM  Sales of Allergan's Older Drugs Dwindle (AGN) at Investopedia
Nov-19-16 08:10PM  Weekly Top Insider Buys Highlight for Week of Nov. 18
Nov-18-16 11:45PM  INVESTOR ALERT: Brower Piven Encourages Shareholders Who Have Losses In Excess Of $100,000 From Investment In Allergan plc To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit Business Wire
09:00PM  No to Closed-End Muni Bond Funds; Cara on a Run: Best of Kass
08:06PM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Allergan plc of Class Action Lawsuit and Upcoming Deadline - AGN PR Newswire
06:45PM  NOTICE TO ALLERGAN CURRENT AND FORMER EMPLOYEES: Zamansky LLC Investigates the Allergan Savings and Investment Plan for Possible ERISA Violations Business Wire
04:42PM  Drugmaker losses pull stocks lower; small-cap surge goes on
11:22AM  Valeant: The Shorts Are Back in Town at Barrons.com
09:03AM  3 Big Drug Stocks That Billionaire Money Managers Dumped in Q3 at Motley Fool
06:22AM  Pharma Stock Roundup: Data Presented at ACR, Bristol-Myers Inks Immuno-Oncology Deal
Nov-17-16 03:27PM  13Fs: Nobody Holds A Monopoly On Brainpower at Forbes
01:15PM  [$$] Teva Takes a Tumble at Barrons.com
12:50PM  Hedge Funds Bought Apple, P&G in Q3; Dumped Allergan, Charter at 24/7 Wall St.
12:24PM  Top Hedge Funds Buy P&G, Apple, BABA But Shed Healthcare at Barrons.com
11:00AM  NYPD Union Goes After Drug Prices Amid DOJ Pharma Probe at Bloomberg
10:14AM  Amgen's Migraine Drug Hits Primary Endpoint in STRIVE Study
10:07AM  Carl Icahn Buys More Herbalife (HLF), Hertz (HTZ), Unloads Energy Stocks at Insider Monkey
10:00AM  The Conference Board Leading Economic Index® for Brazil, Together with Fundação Getulio Vargas (TCB/FGV Brazil LEI), Increased PR Newswire
07:30AM  Allergan to Present at Piper Jaffray 28th Annual Healthcare Conference PR Newswire
04:47AM  Amgen, Novartis aim for big, crowded migraine market after new drug data
Nov-16-16 06:13PM  John Griffin Gains 3 Positions in 3rd Quarter
01:27PM  How This Funds Bets on Allergan, Inc. (AGN), Charter Communications, Inc. (CHTR) & Two Other Stocks Pay Off? at Insider Monkey
01:04PM  ALLERGAN PLC Financials
Allergan plc, a specialty pharmaceutical company, develops, manufactures, markets, and distributes medical aesthetics, biosimilar, and over-the-counter pharmaceutical products worldwide. It operates through US Brands, US Medical Aesthetics, International Brands, and Anda Distribution segments. The company offers a portfolio of products that provide treatments for the central nervous system, gastroenterology, women's health and urology, ophthalmology, neurosciences, medical aesthetics, liver disease, inflammation, fibrosis, and HIV, as well as dermatology and plastic surgery, and Alzheimer's disease. It is also involved in developing ocular implants that reduce intraocular pressure associated with glaucoma; medical devices for the correction of prominent ears; and intranasal neurostimulation devices, as well as other dry eye products. In addition, it distributes generic and branded pharmaceutical products primarily to independent pharmacies, pharmacy chains, pharmacy buying groups, and physicians' offices. Allergan plc has a collaboration with T2 Biosystems to develop blood-based diagnostic panel for the detection of Gram-negative bacterial species. The company was formerly known as Actavis plc and changed its name to Allergan plc in June 2015. Allergan plc was founded in 1983 and is headquartered in Dublin, Ireland.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
SAUNDERS BRENT LCEO and PresidentNov 21Buy189.135,250992,941106,564Nov 21 04:03 PM
Hilado Maria TeresaChief Financial OfficerNov 11Buy210.641,422299,53613,379Nov 15 05:18 PM